메뉴 건너뛰기




Volumn 75, Issue 2, 2009, Pages 124-132

Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

EID: 58849143901     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2008.01146.x     Document Type: Article
Times cited : (44)

References (36)
  • 1
    • 0025613812 scopus 로고
    • Linkage of early-onset familial breast cancer to chromosome 17q21
    • Hall JM, Lee MK, Newman B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990: 250 (4988): 1684-1689.
    • (1990) Science , vol.250 , Issue.4988 , pp. 1684-1689
    • Hall, J.M.1    Lee, M.K.2    Newman, B.3
  • 2
    • 0027433563 scopus 로고
    • Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. The Breast Cancer Linkage Consortium
    • Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993: 52 (4): 678-701.
    • (1993) Am J Hum Genet , vol.52 , Issue.4 , pp. 678-701
    • Easton, D.F.1    Bishop, D.T.2    Ford, D.3    Crockford, G.P.4
  • 3
    • 0028843102 scopus 로고
    • Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
    • Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995: 56 (1): 265-271.
    • (1995) Am J Hum Genet , vol.56 , Issue.1 , pp. 265-271
    • Easton, D.F.1    Ford, D.2    Bishop, D.T.3
  • 4
    • 0028885339 scopus 로고
    • An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium
    • Narod SA, Ford D, Devilee P et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet 1995: 56 (1): 254-264.
    • (1995) Am J Hum Genet , vol.56 , Issue.1 , pp. 254-264
    • Narod, S.A.1    Ford, D.2    Devilee, P.3
  • 5
    • 17344365851 scopus 로고    scopus 로고
    • Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
    • Ford D, Easton D, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998: 2: 676-689.
    • (1998) Am J Hum Genet , vol.2 , pp. 676-689
    • Ford, D.1    Easton, D.2    Stratton, M.3
  • 6
    • 0028113345 scopus 로고
    • A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
    • Miki Y, Swensen J, Shattuck Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994: 266: 66-71.
    • (1994) Science , vol.266 , pp. 66-71
    • Miki, Y.1    Swensen, J.2    Shattuck Eidens, D.3
  • 7
    • 0029121898 scopus 로고
    • Genetic testing in breast/ovarian cancer (BRCA1) families
    • Watson M, Murday V, Lloyd S et al. Genetic testing in breast/ovarian cancer (BRCA1) families. Lancet 1995: 346: 583.
    • (1995) Lancet , vol.346 , pp. 583
    • Watson, M.1    Murday, V.2    Lloyd, S.3
  • 8
    • 15844404355 scopus 로고    scopus 로고
    • BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes
    • Lerman C, Narod S, Schulman K et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996: 275: 1885-1892.
    • (1996) JAMA , vol.275 , pp. 1885-1892
    • Lerman, C.1    Narod, S.2    Schulman, K.3
  • 10
    • 0034528209 scopus 로고    scopus 로고
    • Uptake of hereditary breast ovarian cancer genetic testing in a French national sample of BRCA1 families
    • Julian-Reynier C, Sobol H, Sévilla C et al. Uptake of hereditary breast ovarian cancer genetic testing in a French national sample of BRCA1 families. Psychooncology 2000: 9: 504-510.
    • (2000) Psychooncology , vol.9 , pp. 504-510
    • Julian-Reynier, C.1    Sobol, H.2    Sévilla, C.3
  • 11
    • 0042322237 scopus 로고    scopus 로고
    • Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing
    • Botkin JR, Smith KR, Croyle RT et al. Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet 2003: 118A (3): 201-209.
    • (2003) Am J Med Genet , vol.118 A , Issue.3 , pp. 201-209
    • Botkin, J.R.1    Smith, K.R.2    Croyle, R.T.3
  • 13
    • 0034648501 scopus 로고    scopus 로고
    • Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian families
    • Bowles Biesecker B, Ishibe N, Hadley DW et al. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian families. Am J Med Genet 2000: 93: 257-263.
    • (2000) Am J Med Genet , vol.93 , pp. 257-263
    • Bowles Biesecker, B.1    Ishibe, N.2    Hadley, D.W.3
  • 14
    • 0032954046 scopus 로고    scopus 로고
    • Familial context of genetic testing for cancer susceptibility: Moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing
    • Smith KR, West JA, Croyle RT, Botkin JR. Familial context of genetic testing for cancer susceptibility: Moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol Biomarkers Prev 1999: 8: 385-392.
    • (1999) Cancer Epidemiol Biomarkers Prev , vol.8 , pp. 385-392
    • Smith, K.R.1    West, J.A.2    Croyle, R.T.3    Botkin, J.R.4
  • 15
    • 0032752989 scopus 로고    scopus 로고
    • Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations
    • Reichelt JG, Dahl AA, Heimdal K, Moller P. Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations. Dis Markers 1999: 15: 139-143.
    • (1999) Dis Markers , vol.15 , pp. 139-143
    • Reichelt, J.G.1    Dahl, A.A.2    Heimdal, K.3    Moller, P.4
  • 16
    • 0034631316 scopus 로고    scopus 로고
    • Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
    • Meijers-Heijboer EJ, Verhoog LC, Brekelmans CTM et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000: 355: 2015-2020.
    • (2000) Lancet , vol.355 , pp. 2015-2020
    • Meijers-Heijboer, E.J.1    Verhoog, L.C.2    Brekelmans, C.T.M.3
  • 17
    • 0042405009 scopus 로고    scopus 로고
    • Early adoption of BRCA1/2 testing: Who and why
    • Armstrong K, Weiner J, Weber B, Asch DA. Early adoption of BRCA1/2 testing: Who and why. Genet Med 2003: 5 (2): 92-98.
    • (2003) Genet Med , vol.5 , Issue.2 , pp. 92-98
    • Armstrong, K.1    Weiner, J.2    Weber, B.3    Asch, D.A.4
  • 18
    • 18544376723 scopus 로고    scopus 로고
    • Predictive testing for BRCA1/2: Attributes, risk perception and management in a multi-centre clinical cohort
    • Foster C, Evans DGR, Eeles R et al. Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 2002: 86: 1209-1216.
    • (2002) Br J Cancer , vol.86 , pp. 1209-1216
    • Foster, C.1    Evans, D.G.R.2    Eeles, R.3
  • 19
    • 10844222436 scopus 로고    scopus 로고
    • Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort
    • Watson M, Foster C, Eeles R et al. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 2004: 91 (10): 1787-1794.
    • (2004) Br J Cancer , vol.91 , Issue.10 , pp. 1787-1794
    • Watson, M.1    Foster, C.2    Eeles, R.3
  • 20
    • 33847765415 scopus 로고    scopus 로고
    • Predictive genetic testing for BRCA1/2 in a UK clinical cohort: Three-year follow-up
    • Foster C, Watson M, Eeles R et al. Predictive genetic testing for BRCA1/ 2 in a UK clinical cohort: Three-year follow-up. Br J Cancer 2007: 96 (5): 718-724.
    • (2007) Br J Cancer , vol.96 , Issue.5 , pp. 718-724
    • Foster, C.1    Watson, M.2    Eeles, R.3
  • 21
    • 0142119267 scopus 로고    scopus 로고
    • Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study
    • van Oostrom I, Meijers-Heijboer H, Ladder LN et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study. J Clin Oncol 2003: 21: 3867-3874.
    • (2003) J Clin Oncol , vol.21 , pp. 3867-3874
    • van Oostrom, I.1    Meijers-Heijboer, H.2    Ladder, L.N.3
  • 22
    • 0028330276 scopus 로고
    • Risks of cancer in BRCA1 mutation carriers
    • Ford D, Easton D, Bishop DT, Narod S, Goldgar D, BCLC Consortium. Risks of cancer in BRCA1 mutation carriers. Lancet 1994: 343: 692-695.
    • (1994) Lancet , vol.343 , pp. 692-695
    • Ford, D.1    Easton, D.2    Bishop, D.T.3    Narod, S.4    Goldgar, D.5
  • 23
    • 0037130887 scopus 로고    scopus 로고
    • Cancer incidence in BRCA1 mutation carriers
    • Thompson D, Easton DF; Breast Cancer Linkage Consortium. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002: 94 (18): 1358-1365.
    • (2002) J Natl Cancer Inst , vol.94 , Issue.18 , pp. 1358-1365
    • Thompson, D.1    Easton, D.F.2
  • 24
    • 4444316405 scopus 로고    scopus 로고
    • BRCA1/2 predictive testing: A study of uptake in two centres
    • Brooks L, Lennard F, Shenton A et al. BRCA1/2 predictive testing: A study of uptake in two centres. Eur J Hum Genet 2004: 12 (8): 654-662.
    • (2004) Eur J Hum Genet , vol.12 , Issue.8 , pp. 654-662
    • Brooks, L.1    Lennard, F.2    Shenton, A.3
  • 25
    • 0031847821 scopus 로고    scopus 로고
    • Men in breast cancer families: A preliminary study on awareness and perception
    • McAllister M, Evans DGR, Ormiston W et al. Men in breast cancer families: A preliminary study on awareness and perception. J Med Genet 1998: 35: 739-744.
    • (1998) J Med Genet , vol.35 , pp. 739-744
    • McAllister, M.1    Evans, D.G.R.2    Ormiston, W.3
  • 27
    • 0037216727 scopus 로고    scopus 로고
    • Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients
    • Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A 2003: 116 (1): 11-19.
    • (2003) Am J Med Genet A , vol.116 , Issue.1 , pp. 11-19
    • Claes, E.1    Evers-Kiebooms, G.2    Boogaerts, A.3    Decruyenaere, M.4    Denayer, L.5    Legius, E.6
  • 28
    • 0035104727 scopus 로고    scopus 로고
    • Risk perception and cancer worry: An exploratory study of the impact of genetic risk counselling and bereavement in women with a family history of breast cancer
    • Hopwood P, Shenton A, Lalloo F, Evans DGR, Howell A. Risk perception and cancer worry: An exploratory study of the impact of genetic risk counselling and bereavement in women with a family history of breast cancer. J Med Genet 2001: 38: 139-142.
    • (2001) J Med Genet , vol.38 , pp. 139-142
    • Hopwood, P.1    Shenton, A.2    Lalloo, F.3    Evans, D.G.R.4    Howell, A.5
  • 29
    • 21244473319 scopus 로고    scopus 로고
    • Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients
    • Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Fam Cancer 2005: 4 (2): 115-119.
    • (2005) Fam Cancer , vol.4 , Issue.2 , pp. 115-119
    • Landsbergen, K.1    Verhaak, C.2    Kraaimaat, F.3    Hoogerbrugge, N.4
  • 30
    • 33747057716 scopus 로고    scopus 로고
    • Letting the family know: Balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder
    • Suthers GK, Armstrong J, McCormack J, Trott D. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 2006: 43 (8): 665-670.
    • (2006) J Med Genet , vol.43 , Issue.8 , pp. 665-670
    • Suthers, G.K.1    Armstrong, J.2    McCormack, J.3    Trott, D.4
  • 31
    • 36349002802 scopus 로고    scopus 로고
    • Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing
    • Aktan-Collan K, Haukkala A, Pylvänäinen K et al. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet 2007: 44 (11): 732-738.
    • (2007) J Med Genet , vol.44 , Issue.11 , pp. 732-738
    • Aktan-Collan, K.1    Haukkala, A.2    Pylvänäinen, K.3
  • 32
    • 0027000793 scopus 로고
    • The use of information (autonomy and confidentiality)
    • Harris J. The use of information (autonomy and confidentiality). Dis Markers 1992: 10: 195-198.
    • (1992) Dis Markers , vol.10 , pp. 195-198
    • Harris, J.1
  • 33
    • 0031448740 scopus 로고    scopus 로고
    • Breast cancer, the genetic "quick fix"and the Jewish community
    • Rothenberg KH. Breast cancer, the genetic "quick fix"and the Jewish community. Health Matrix Clevel 1997: 7: 97-124.
    • (1997) Health Matrix Clevel , vol.7 , pp. 97-124
    • Rothenberg, K.H.1
  • 34
    • 4544245238 scopus 로고    scopus 로고
    • The "duty to warn"a patient's family members about hereditary disease risks
    • Offit K, Groeger E, Turner S, Wadsworth EA, Weiser MA. The "duty to warn"a patient's family members about hereditary disease risks. JAMA 2004: 292 (12): 1469-1473.
    • (2004) JAMA , vol.292 , Issue.12 , pp. 1469-1473
    • Offit, K.1    Groeger, E.2    Turner, S.3    Wadsworth, E.A.4    Weiser, M.A.5
  • 35
    • 0031991614 scopus 로고    scopus 로고
    • ASHG statement: Professional disclosure of familial genetic information
    • ASHG statement: Professional disclosure of familial genetic information. Am J Hum Genet 1998: 62: 474-483.
    • (1998) Am J Hum Genet , vol.62 , pp. 474-483


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.